Yahoo Search Búsqueda en la Web

Resultado de búsqueda

1. www.linkedin.com › in › james-wilbur-a726bb32James Wilbur - 10x Genomics | LinkedIn

   www.linkedin.com › in › james-wilbur-a726bb32

   View James Wilbur’s profile on LinkedIn, a professional community of 1 billion members. Experience: 10x Genomics · Education: Harvard University · Location: Washington DC-Baltimore Area · 500...

2. www.prnewswire.com › news-releases › 10x-genomics-names-jim-wilbur-as-chief10x Genomics Names Jim Wilbur as Chief Commercial Officer - PR...

   www.prnewswire.com › news-releases › 10x-genomics-names-jim-wilbur-as-chief

   • En caché

   14 de jul. de 2022 · Wilbur joins 10x Genomics from Meso Scale Discovery (MSD), the world's leading provider of highly sensitive multiplex immunoassays.

3. www.facebook.com › public › Jim-WilburJim Wilbur Profiles | Facebook

   www.facebook.com › public › Jim-Wilbur

   View the profiles of people named Jim Wilbur. Join Facebook to connect with Jim Wilbur and others you may know. Facebook gives people the power to share...

4. theorg.com › org › 10x-genomicsJim Wilbur - Chief Commercial Officer at 10X Genomics | The Org

   theorg.com › org › 10x-genomics

   • En caché

   A life sciences entrepreneur and seasoned global commercial executive, Wilbur offers nearly 30 years of experience building businesses, developing high-performance teams and scaling commercial organizations to drive growth and customer success.

5. Imágenes

   • 
   • 
   • 
   • 
   • 

   Ver todo

6. www.sec.gov › Archives › edgarDocument - SEC.gov

   www.sec.gov › Archives › edgar

   • En caché

   PLEASANTON, Calif., July 14, 2022 — Following a comprehensive search process, 10x Genomics, Inc. (Nasdaq: TXG), today announced the hiring of Jim Wilbur, Ph.D., as Chief Commercial Officer, effective July 27.

7. www.marketscreener.com › quote › stockJames Wilbur to Depart from 10X Genomics, Inc. as Chief...

   www.marketscreener.com › quote › stock

   • En caché

   16 de ene. de 2024 · On January 15, 2024, Chief Commercial Officer James Wilbur and 10x Genomics, Inc. (the ?Company?) entered into a Transition and Separation Agreement (the ?Agreement?) pursuant to which Dr. Wilbur will depart the Company on February 1, 2024.

8. markets.businessinsider.com › news › stocks10x Genomics Names Jim Wilbur as Chief Commercial Officer

   markets.businessinsider.com › news › stocks

   • En caché

   14 de jul. de 2022 · Wilbur joins 10x Genomics from Meso Scale Discovery (MSD), the world's leading provider of highly sensitive multiplex immunoassays.